These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9204209)

  • 1. Lipoprotein (a) serum levels in patients with hepatocarcinoma.
    Basili S; Andreozzi P; Vieri M; Maurelli M; Cara D; Cordova C; Alessandri C
    Clin Chim Acta; 1997 Jun; 262(1-2):53-60. PubMed ID: 9204209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis.
    Alessandri C; Basili S; Maurelli M; Andreozzi P; Violi F; Cordova C
    Clin Chim Acta; 1994 Jan; 224(2):125-9. PubMed ID: 8004782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein (a) behaviour in patients with hepatocellular carcinoma.
    Motta M; Giugno I; Ruello P; Pistone G; Di Fazio I; Malaguarnera M
    Minerva Med; 2001 Oct; 92(5):301-5. PubMed ID: 11675573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma lipoprotein(a) levels and hypoalbuminemia in peritoneal dialysis patients.
    Ross EA; Shah GM; Kashyap ML
    Int J Artif Organs; 1995 Dec; 18(12):751-6. PubMed ID: 8964640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoprotein (a) levels in chronic renal failure and liver cirrhosis patients. Relationship with atherosclerosis.
    Mady E; Wissa G; Khalifa A; el-Sabbagh M
    Dis Markers; 1999 Dec; 15(4):237-47. PubMed ID: 10689547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
    Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosis.
    Hachem H; Favre G; Raynal G; Blavy G; Canal P; Soula G
    J Clin Chem Clin Biochem; 1986 Mar; 24(3):161-6. PubMed ID: 2872262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits.
    Spadaro A; Ajello A; Morace C; Zirilli A; D'arrigo G; Luigiano C; Martino F; Bene A; Migliorato D; Turiano S; Ferraù O; Freni MA
    World J Gastroenterol; 2005 Apr; 11(13):1987-90. PubMed ID: 15800991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.
    Noto D; Barbagallo CM; Cascio AL; Cefalù AB; Cavera G; Caldarella R; Marino G; Travali S; Cutaia I; Maringhini S; Notarbartolo A; Averna M
    Kidney Int; 1999 Jun; 55(6):2433-9. PubMed ID: 10354292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response.
    Lippi G; Braga V; Adami S; Guidi G
    Clin Chim Acta; 1998 Mar; 271(1):79-87. PubMed ID: 9564559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
    Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
    BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
    Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
    Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
    Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum talin-1 is a potential novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
    Youns MM; Abdel Wahab AH; Hassan ZA; Attia MS
    Asian Pac J Cancer Prev; 2013; 14(6):3819-23. PubMed ID: 23886189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
    PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
    Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease.
    Ben-Ari Z; Tur-Kaspa R; Schafer Z; Baruch Y; Sulkes J; Atzmon O; Greenberg A; Levi N; Fainaru M
    J Investig Med; 2001 Jul; 49(4):325-9. PubMed ID: 11478408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
    Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.